Western Digital Gains on Solid Q2 Guidance Update
Western Digital shares saw a handy gain early on Wednesday after the company issued an update to its fiscal second-quarter guidance.
All Work
Chris Lange
Dave & Buster’s Wows on Earnings and Guidance
Dave & Buster's Entertainment reported better than expected fiscal third-quarter financial results after the markets closed on Tuesday.
SEC Settles Charges With Firm Over Unregistered Swaps in Pre-IPO Companies
The U.S. Securities and Exchange Commission (SEC) recently announced that a San Francisco-based firm has agreed to settle charges that it violated federal securities laws by failing to register security-based swaps that were offered…
SEC Announces Insider Trading Charges Against IT Specialist
The U.S. Securities and Exchange Commission (SEC) recently announced insider trading charges against a San Francisco-based IT specialist who allegedly hacked senior executives at online travel company Expedia and illegally traded on company secrets.…
Conn’s Rises on Mixed Q3 Results
Conn's reported mixed fiscal third-quarter financial results before the markets opened on Tuesday.
Equinix Grows on Data Center Acquisition
Equinix shares saw a handy gain on Tuesday after the company announced that it is purchasing a portfolio of 24 data center sites and their operations from Verizon for $3.6 billion.
Teva Shares Slide on Management Change
Teva Pharmaceutical Industries shares sank on Tuesday after the company announced the appointment of Dipankar Bhattacharjee as chief executive for its global generic medicines group.
Reata Pharma Files for Secondary Offering
Reata Pharmaceuticals has filed an S-1 form with the U.S. Securities and Exchange Commission for a secondary offering.
Michaels Sinks on Q3 Results
Michaels Companies reported disappointing fiscal third-quarter financial results before the markets opened on Tuesday.
AutoZone Delivers Mixed Q1 Earnings Report
AutoZone Inc. (NYSE: AZO) reported its fiscal first-quarter financial results before the markets opened on Tuesday. The company said that it had $9.36 in earnings per share (EPS) and $2.47 billion in revenue, versus…
Atkore Files for Secondary Offering
Atikore International intends to sell 8 million shares in a secondary offering that is valued at up to more than $188 million.
Trivago Announces Potential Pricing for IPO
Travel B.V., also known as Trivago, has filed an amended Form F-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company expects to price 28.53 million American…
Hudson Technologies Gears Up For Secondary Offering
Hudson Technologies Inc. (NASDAQ: HDSN) saw its shares fall on Monday after the company announced a secondary offering of its common stock. The company said that it intends to offering up to $45 million…
SEC Awards $3.5 Million to Whistleblower
The U.S. Securities and Exchange Commission (SEC) recently announced that a whistleblower has been awarded roughly $3.5 million for coming forward with meaningful information that led to an SEC enforcement action. So far the…
10 Major Pharma and FDA Catalysts Coming in December
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
EyeGate Pharmaceuticals Continues to Win in Mid-Stage Trial
EyeGate Pharmaceuticals shares rose about 10% on Monday after the company announced promising data from its mid-stage trial of its leading product candidate.
NeuroDerm Jumps on Critical FDA Update
NeuroDerm has announced that it intends to pursue a comparative bioavailability regulatory path for the its lead product candidate ND0612 based on comparative pharmacokinetic data in place of data from Phase 3 clinical efficacy…
Consolidated Communications Moves to Acquire FairPoint
Consolidated Communications saw its shares pull back early Monday, after the company announced that it will acquire FairPoint Communications in an all-stock merger transaction valued up to $1.5 billion
GW Pharmaceuticals Shows Smaller Than Expected Q4 Loss
GW Pharmaceuticals reported its fiscal fourth-quarter financial results before the markets opened on Monday.
Cempra Rises on Late-Stage Trial
Shares of Cempra saw a handy gain early Monday after Toyama Chemical announced that it had begun Phase 3 clinical trials with solithromycin in Japan for patients with respiratory infections.